Project description
Imaging technology for assessment of patient immune status
Immunotherapy can effectively treat a number of serious conditions such as cancer and inflammatory diseases but a personalised approach is key. Blood and tissue markers coupled with non-invasive imaging could aid in assessing immune status in vivo, but this option has barely been explored. To this end, the EU-funded project will develop new immunotracers for imaging specific immune cell subsets, and then validate them in relevant disease models. The goal is to transfer them to manufacturing and then conduct smart clinical trials. This international multi-disciplinary consortium will work on optimising molecular imaging techniques for assessing patient immune status via immunotracers and developing personalised immunotherapeutic drugs.
Fields of science
Programme(s)
Funding Scheme
IMI2-RIA - Research and Innovation actionCoordinator
1081 HV Amsterdam
Netherlands
See on map
Participants (24)
72074 Tuebingen
See on map
CB2 1TN Cambridge
See on map
48149 Muenster
See on map
1050 Brussel
See on map
9052 Zwijnaarde - Gent
See on map
9713 GZ Groningen
See on map
08035 Barcelona
See on map
08035 Barcelona
See on map
75015 Paris 15
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
91190 Gif-sur-yvette
See on map
431 83 Molndal
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
3521 AL Utrecht
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
3584 BL Utrecht
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
2289 DC Rijswijk
See on map
1016 XX Amsterdam
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
1000 Bruxelles
See on map
4070 Basel
See on map
51373 Leverkusen
See on map
2340 Beerse
See on map
4056 Basel
See on map
CT13 9NJ Sandwich
See on map
90301 Inglewood Ca
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Participation ended
WC2B 4AE London
See on map
8152 Glattpark
See on map